Tuberculosis (TB) remains one of humanity’s oldest and most persistent health challenges. Despite significant medical advances, this infectious disease continues to affect millions globally, with ...

A new study revealed that specific drug-resistance patterns in tuberculosis are linked to altered gene transcription and ...

Tuberculosis (TB) was the leading cause of death in the United States in the 19th and 20th centuries. By 1900, TB—which usually attacks the lungs but can affect almost any part of the body—had killed ...

The novel antibiotic candidate sorfequiline has the potential to shorten and improve tuberculosis (TB) treatment when combined with pretomanid and linezolid (SPaL), according to new clinical trial ...

Tuberculosis – the world’s deadliest infectious disease – could be dormant in your system for years before you realize you have it. In the... We have the cure. Why is tuberculosis still around?

Across the spectrum of human afflictions—from cancer to heart disease to rare genetic conditions—medical investigators are continually attempting to break new ground by developing better methods of ...

For adolescents aged 14 years and older and adults with rifampin-resistant pulmonary TB, a 6-month bedaquiline, pretomanid, and linezolid regimen is as efficacious and safe as the current 15-month or ...

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

Researcher found that exposed individuals with confirmed TB infection -- i.e. a positive skin or blood test -- should receive priority treatment in settings with a low prevalence of the disease, ...

Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and causes organs to fail. Africa bears the world's highest burden of sepsis, with ...